Results 171 to 180 of about 47,826 (189)

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin

Annals of Oncology, 2002
R L Schilsky, J Mckendrick, U Graeven
exaly  

Capecitabine

Reactions Weekly, 2013
openaire   +1 more source

Capecitabine in early breast cancer: A meta-analysis of randomised controlled trials

European Journal of Cancer, 2017
David W Cescon, Eitan Amir, Josee-Lyne Éthier   +2 more
exaly  

Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer

Annals of Oncology, 2003
Virginia Ferraresi, Diana Giannarelli, Francesco Cognetti   +2 more
exaly  

Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature

Annals of Oncology, 2005
Vicente Valero
exaly  

Capecitabine

Reactions Weekly, 2012
openaire   +1 more source

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer

Annals of Oncology, 2007
A Kartheuser, P Scalliet, S Roels
exaly  

Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma

Annals of Oncology, 2009
Y J Bang, T Y Kim, S A Im
exaly  

Capecitabine

Reactions Weekly, 2021
openaire   +1 more source

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Annals of Oncology, 2009
Yoon-Koo Kang, M Lichinitser, Y-K Kang   +2 more
exaly